High seeding efficiencies and improved outgrowth of clones can be achieved, says Solentim, by combining a CHO knockout cell line, the right media, and the VIPS platform.
Acquisition will significantly expand buyer's capabilities by adding research and development, formulation, lab analysis and commercial and clinical manufacturing
Company now has nine such facilities in major global regions.
AlbuPure was derived from ProMetic’s Mimetic Ligand platform. It was designed for the development of albufuse albumin-fusion molecules.
Partnership will exploit nuclease technology to develop biosimilars.
Goal is to increase the productivity and quality of vaccine and mAb production. Xcellerex, Dowpharma, Biopharm Services, and deltaDot have been awarded $11 million to develop technology that accelerates mAb and vaccine manufacturing. DTRA’s Joint...
Award focused on manufacturing and storage of the companies’ Ebola prime-boost vaccine regimen candidate.
Thermo Fisher Scientific has agreed to acquire Brammer Bio for $1.7 billion cash, the companies said, in a deal designed to increase the buyer’s presence in gene therapy with the viral vector contract development...
Please wait while you are redirected to the right page...